MX360479B - Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. - Google Patents

Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.

Info

Publication number
MX360479B
MX360479B MX2015004271A MX2015004271A MX360479B MX 360479 B MX360479 B MX 360479B MX 2015004271 A MX2015004271 A MX 2015004271A MX 2015004271 A MX2015004271 A MX 2015004271A MX 360479 B MX360479 B MX 360479B
Authority
MX
Mexico
Prior art keywords
ibs
markers
microbiome
antibodies
mast cell
Prior art date
Application number
MX2015004271A
Other languages
English (en)
Spanish (es)
Other versions
MX2015004271A (es
Inventor
Singh Sharat
Lockton Steven
Chi-Kwan Ling Nicholas
Wang Shui-Long
Princen Fred
Westin Stefan
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2015004271A publication Critical patent/MX2015004271A/es
Publication of MX360479B publication Critical patent/MX360479B/es

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • G01N2800/065Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2015004271A 2012-10-05 2013-10-01 Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs. MX360479B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261710574P 2012-10-05 2012-10-05
US201361871853P 2013-08-29 2013-08-29
PCT/IB2013/059045 WO2014053996A2 (en) 2012-10-05 2013-10-01 Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs

Publications (2)

Publication Number Publication Date
MX2015004271A MX2015004271A (es) 2015-08-14
MX360479B true MX360479B (es) 2018-11-05

Family

ID=49447585

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015004271A MX360479B (es) 2012-10-05 2013-10-01 Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.

Country Status (9)

Country Link
US (1) US10184940B2 (enExample)
EP (1) EP2904395B1 (enExample)
JP (1) JP6329553B2 (enExample)
CN (1) CN104884959B (enExample)
AU (1) AU2013326133B2 (enExample)
CA (1) CA2886991A1 (enExample)
MX (1) MX360479B (enExample)
SG (2) SG11201502641YA (enExample)
WO (1) WO2014053996A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0720250D0 (en) * 2007-10-17 2007-11-28 Univ Edinburgh Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof
US20160096819A1 (en) * 2013-05-17 2016-04-07 Basf Se Process for preparing n-substituted 1h-pyrazole-5-carboxylic acid compounds and derivatives thereof
RU2015155552A (ru) 2013-05-24 2017-06-27 Нестек С.А. Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника
WO2017079653A2 (en) 2015-11-06 2017-05-11 Vetica Labs, Inc. Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
EP3421616A1 (en) * 2017-06-29 2019-01-02 Tata Consultancy Services Limited Method and system for monitoring the gut health of an individual
CN111432825A (zh) * 2017-10-03 2020-07-17 赛里斯治疗公司 色胺代谢的操纵
JP6533930B1 (ja) * 2018-08-23 2019-06-26 一般社団法人日本農業フロンティア開発機構 疾病評価指標算出方法、装置、システム、及び、プログラム、並びに、疾病評価指標を算出するためのモデル作成方法。
US11884958B2 (en) 2019-04-30 2024-01-30 Mayo Foundation For Medical Education And Research Assessing and treating functional gastrointestinal disorders
WO2025071560A1 (en) * 2023-09-28 2025-04-03 Rutgers, The State University Of New Jersey Methods of diagnosing b cell malignancies, detecting b cell malignancy relapse, and treating thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003298703A1 (en) * 2002-11-22 2004-06-18 Emory University Diagnostic tests and methods for diagnosing inflammatory bowel disease
US20060154276A1 (en) * 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7943328B1 (en) * 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
WO2011027971A2 (ko) * 2009-09-01 2011-03-10 주식회사이언메딕스 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법
EP2494074A4 (en) * 2009-10-30 2013-06-12 Nestec Sa METHOD FOR DIAGNOSING IRRITATION SYNDROME

Also Published As

Publication number Publication date
EP2904395A2 (en) 2015-08-12
SG10201702773QA (en) 2017-06-29
US10184940B2 (en) 2019-01-22
EP2904395B1 (en) 2018-09-05
WO2014053996A3 (en) 2014-05-30
CA2886991A1 (en) 2014-04-10
SG11201502641YA (en) 2015-05-28
CN104884959A (zh) 2015-09-02
AU2013326133B2 (en) 2019-07-04
JP6329553B2 (ja) 2018-05-23
JP2015533213A (ja) 2015-11-19
CN104884959B (zh) 2017-12-01
US20150346200A1 (en) 2015-12-03
MX2015004271A (es) 2015-08-14
HK1213050A1 (en) 2016-06-24
WO2014053996A2 (en) 2014-04-10
AU2013326133A1 (en) 2015-04-23

Similar Documents

Publication Publication Date Title
MX360479B (es) Anticuerpos contra microbioma, factores de estres y marcadores de mastocitos como marcadores de diagnostico para ibs.
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
NZ628458A (en) Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
GB2519906A (en) Methods and systems for detecting biological components
EA201590027A1 (ru) Способы детекции заболеваний или состояний
WO2013190075A3 (en) Specific biomarkers for hepatocellular carcinoma (hcc)
MX358541B (es) Metodos para predecir el riesgo de desarrollar hipertension.
WO2013033609A3 (en) Methods and compositions for the treatment and diagnosis of cancer
EA201391187A1 (ru) Способ диагностики злокачественной опухоли и набор для диагностики путем измерения активности nk-клеток
PH12013502340A1 (en) Biomarkers for hedgehog inhibitor therapy
NZ621733A (en) Lung cancer biomarkers and uses thereof
MX357429B (es) Predictores para el tratamiento del cáncer.
WO2016198833A3 (en) Methods for analysing a urine sample
MX358474B (es) Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson.
WO2014078468A3 (en) Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent
MX2015001961A (es) Metodos y sistemas para ensayos.
MX381530B (es) Método in vitro para el diagnóstico de la enfermedad de niemann-pick.
NZ729773A (en) Biomarkers for disease progression in melanoma
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
WO2013167727A3 (en) Method for determining arthritis relapse risk
EP3502702A3 (en) Prediction of recurrence for bladder cancer by a protein signature in tissue samples
WO2015013455A3 (en) Methods and compositions for the treatment and diagnosis of cancer
GB201114909D0 (en) Biomarkers for lysosomal storage disorders
WO2014160237A3 (en) Methods of prognosing preeclampsia

Legal Events

Date Code Title Description
FG Grant or registration